Effect of epoetin beta on survival, tumor progression and thromboembolic events in patients with lymphoid malignancies receiving chemotherapy:: A meta-analysis of controlled clinical studies

被引:0
|
作者
Coiffier, B
Boogaerts, M
Österborg, A
Burger, HU
机构
[1] Ctr Hosp Lyon Sud, Hematol Serv, Pierre Benite, France
[2] Katholieke Univ Leuven, Louvain, Belgium
[3] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[4] F Hoffmann La Roche & Co Ltd, Dept Biostat, CH-4002 Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3149
引用
收藏
页码:861A / 861A
页数:1
相关论文
共 50 条
  • [1] Effect of epoetin beta on tumour progression and survival in patients with cancer: a meta-analysis of controlled clinical studies
    Aapro, Matti
    Dunst, Juergen
    Morere, Jean-Francois
    Nowrousian, Mohammed R.
    Huber, Marty
    Burger, Hans-Ulrich
    ANNALS OF ONCOLOGY, 2004, 15 : 222 - 222
  • [2] Thromboembolic events in patients with cancer treated with epoetin beta: A meta-analysis of controlled clinical trials
    Coiffier, Bertrand
    Boogaerts, Marc
    Aapro, Matti
    Huber, Marty
    Burger, Hans-Ulrich
    ANNALS OF ONCOLOGY, 2004, 15 : 221 - 221
  • [3] Risk factors for thromboembolic events with Neorecormon® (epoetin beta):: A meta-analysis of controlled clinical trials
    Coiffier, B
    Boogaerts
    Aapro, M
    Hayward, C
    Burger, H
    ANNALS OF ONCOLOGY, 2005, 16 : 216 - 216
  • [4] Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients
    M Aapro
    A Scherhag
    H U Burger
    British Journal of Cancer, 2008, 99 : 14 - 22
  • [5] Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer:: an updated meta-analysis of 12 randomised controlled studies including 2301 patients
    Aapro, M.
    Scherhag, A.
    Burger, H. U.
    BRITISH JOURNAL OF CANCER, 2008, 99 (01) : 14 - 22
  • [6] Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer:: a meta-analysis
    Aapro, M.
    Coiffier, B.
    Dunst, J.
    Osterborg, A.
    Burger, H. U.
    BRITISH JOURNAL OF CANCER, 2006, 95 (11) : 1467 - 1473
  • [7] Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis
    M Aapro
    B Coiffier
    J Dunst
    A Österborg
    H U Burger
    British Journal of Cancer, 2006, 95 : 1467 - 1473
  • [8] Epoetin beta with intravenous iron results in overall cost savings in a population of anemic patients with lymphoid malignancies not receiving chemotherapy.
    Hedenus, Michael
    Nasman, Per
    BLOOD, 2007, 110 (11) : 377B - 377B
  • [9] Epoetin beta (NeoRecormon®) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy:: a meta-analysis
    Boogaerts, M
    Oberhoff, C
    Huinink, WTB
    Nowrousian, MR
    Hayward, CRW
    Burger, HU
    ANTICANCER RESEARCH, 2006, 26 (1B) : 479 - 484
  • [10] Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials
    Alahmari, Abdullah K.
    Almalki, Ziyad S.
    Alahmari, Ahmed K.
    Guo, Jeff J.
    AMERICAN HEALTH AND DRUG BENEFITS, 2016, 9 (04): : 221 - 231